The FDA is expected to take another look at controversial diabetes drug Avandia after researchers at Duke have concluded the drug doesn't increase the risk of cardiovascular death as previously reported.
A ballot initiative in Richmond and El Monte proposes a tax on sugar-sweetened drinks. Proponents say it could help prevent diabetes among low-income residents and generate revenue, but the soft drink industry is spending millions to block it.